TIMOTHY DICKEY: Open Payments
NPI 1750621579 · COLUMBIA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,918 in 199 payments from 22 companies in 2025. Trend: 2023 $2,994 · 2024 $3,490 · 2025 $3,918
Food & beverage: $3,918
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 61 | $1,278 |
| Madrigal Pharmaceuticals | 14 | $463 |
| Aimmune Therapeutics, Inc. | 10 | $284 |
| Janssen Biotech, Inc. | 15 | $264 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $243 |
| Ipsen Biopharmaceuticals, Inc | 11 | $177 |
| Ardelyx, Inc. | 9 | $146 |
| Ferring Pharmaceuticals Inc. | 5 | $124 |
| Phathom Pharmaceuticals, Inc. | 9 | $106 |
Products named: REZDIFFRA, RINVOQ, SKYRIZI, ZENPEP, TREMFYA, XIFAXAN, ENTYVIO, IQIRVO.
Industry payments across TN — which companies pay providers there.
